Human cerberus prevents nodal-receptor binding, inhibits nodal signaling, and suppresses nodal-mediated phenotypes

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Aykul, Senem ^a   Ni, Wendi ^a   Mutatu, Washington ^a   Martinez Hackert, Erik ^a  

^a Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERBERUS PROTEIN; PROTEIN NODAL; SECRETORY PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; ACVR1B PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LIGAND; PROTEIN BINDING; SIGNAL PEPTIDE; TDGF1 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CELL INVASION; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; ANIMAL; BREAST TUMOR; CELL LINE; CELL PROLIFERATION; FEMALE; KINETICS; METABOLISM; PATHOLOGY; TUMOR INVASION;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BREAST NEOPLASMS; CELL LINE; CELL PROLIFERATION; CYTOKINES; FEMALE; GPI-LINKED PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; LIGANDS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NODAL PROTEIN; PHENOTYPE; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84929501032     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114954     Document Type: Article

References (58)

1. Shen MM (2007) Nodal signaling: developmental roles and regulation. Development 134: 1023-1034. doi: 10.1242/dev.000166 PMID: 17287255
2. Zhou X, Sasaki H, Lowe L, Hogan BL, Kuehn MR (1993) Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation. Nature 361: 543-547. doi: 10.1038/361543a0 PMID: 8429908
3. Varlet I, Collignon J, Robertson EJ (1997) Nodal expression in the primitive endoderm is required for specification of the anterior axis during mouse gastrulation. Development 124: 1033-1044. PMID: 9056778
4. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, et al. (2008) Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proceedings of the National Academy of Sciences of the United States of America 105: 4329-4334. doi: 10.1073/pnas.0800467105 PMID: 18334633
5. Bianco C, Adkins HB, Wechselberger C, Seno M, Normanno N, et al. (2002) Cripto-1 activates nodaland ALK4-dependent and -independent signaling pathways in mammary epithelial Cells. Molecular and cellular biology 22: 2586-2597. doi: 10.1128/MCB.22.8.2586-2597.2002 PMID: 11909953
6. Papageorgiou I, Nicholls PK, Wang F, Lackmann M, Makanji Y, et al. (2009) Expression of nodal signalling components in cycling human endometrium and in endometrial cancer. Reproductive biology and endocrinology: RB&E 7: 122. doi: 10.1186/1477-7827-12-91 PMID: 25245493
7. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, et al. (2006) Isolation and characterization of a stem cell population from adult human liver. Stem Cells 24: 2840-2850. doi: 10.1634/stemcells.2006-0114 PMID: 16945998
8. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, et al. (2006) Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nature medicine 12: 925-932. doi: 10.1038/nm1448 PMID: 16892036
9. Lonardo E, Hermann PC, Mueller MT, Huber S, Balic A, et al. (2011) Nodal/Activin signaling drives selfrenewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell stem cell 9: 433-446. doi: 10.1016/j.stem.2011.10.001 PMID: 22056140
10. Quail DF, Zhang G, Walsh LA, Siegers GM, Dieters-Castator DZ, et al. (2012) Embryonic morphogen nodal promotes breast cancer growth and progression. PloS one 7: e48237. doi: 10.1371/journal. pone.0048237 PMID: 23144858
11. Strizzi L, Hardy KM, Margaryan NV, Hillman DW, Seftor EA, et al. (2012) Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer. Breast Cancer Res 14: R75. doi: 10.1186/bcr3185 PMID: 22577960
12. Strizzi L, Postovit LM, Margaryan NV, Seftor EA, Abbott DE, et al. (2008) Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast disease 29: 91-103. PMID: 19029628
13. Quail DF, Zhang G, Findlay SD, Hess DA, Postovit LM (2013) Nodal promotes invasive phenotypes via a mitogen-activated protein kinase-dependent pathway. Oncogene. PMID: 23334323
14. Fang R, Zhang G, Guo Q, Ning F, Wang H, et al. (2013) Nodal promotes aggressive phenotype via Snail-mediated epithelial-mesenchymal transition in murine melanoma. Cancer Lett. doi: 10.1016/j. canlet.2013.01.014
15. Petersen M, Thorikay M, Deckers M, van Dinther M, Grygielko ET, et al. (2008) Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis. Kidney International 73: 705-715. doi: 10.1038/sj.ki.5002717 PMID: 18075500
16. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, et al. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74. doi: 10.1124/mol.62.1.65 PMID: 12065756
17. Chen C, Shen MM (2004) Two modes by which Lefty proteins inhibit nodal signaling. Current biology: CB 14: 618-624. doi: 10.1016/j.cub.2004.02.042 PMID: 15062104
18. Piccolo S, Agius E, Leyns L, Bhattacharyya S, Grunz H, et al. (1999) The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature 397: 707-710. doi: 10.1038/17820 PMID: 10067895
19. Meno C, Gritsman K, Ohishi S, Ohfuji Y, Heckscher E, et al. (1999) Mouse Lefty2 and zebrafish antivin are feedback inhibitors of nodal signaling during vertebrate gastrulation. Molecular cell 4: 287-298. doi: 10.1016/S1097-2765(00)80331-7 PMID: 10518210
20. Sakuma R, Ohnishi Yi Y, Meno C, Fujii H, Juan H, et al. (2002) Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion. Genes to cells: devoted to molecular & cellular mechanisms 7: 401-412. doi: 10.1046/j.1365-2443.2002.00528.x
21. Marques S, Borges AC, Silva AC, Freitas S, Cordenonsi M, et al. (2004) The activity of the Nodal antagonist Cerl-2 in the mouse node is required for correct L/R body axis. Genes Dev 18: 2342-2347. doi: 10.1101/gad.306504 PMID: 15466485
22. Bertocchini F, Stern CD (2002) The hypoblast of the chick embryo positions the primitive streak by antagonizing nodal signaling. Dev Cell 3: 735-744. doi: 10.1016/S1534-5807(02)00318-0 PMID: 12431379
23. Belo JA, Bachiller D, Agius E, Kemp C, Borges AC, et al. (2000) Cerberus-like is a secreted BMP and nodal antagonist not essential for mouse development. Genesis 26: 265-270. doi: 10.1002/(SICI) 1526-968X(200004)26:4%3C265::AID-GENE80%3E3.3.CO;2-W PMID: 10748465
24. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, et al. (2007) Reprogramming metastatic tumour cells with embryonic microenvironments. Nature reviews Cancer 7: 246-255. doi: 10. 1038/nrc2108 PMID: 17384580
25. Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67: 753-791. doi: 10.1146/ annurev.biochem.67.1.753 PMID: 9759503
26. Yeo C, Whitman M (2001) Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Molecular cell 7: 949-957. doi: 10.1016/S1097-2765(01)00249-0 PMID: 11389842
27. Reissmann E, Jornvall H, Blokzijl A, Andersson O, Chang C, et al. (2001) The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes & development 15: 2010-2022. doi: 10.1101/gad.201801
28. Vallier L, Mendjan S, Brown S, Chng Z, Teo A, et al. (2009) Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 136: 1339-1349. doi: 10.1242/dev.033951 PMID: 19279133
29. Zhang C, KlymkowskyMW(2009) Unexpected functional redundancy between Twist and Slug (Snail2) and their feedback regulation of NF-kappaB via Nodal and Cerberus. Dev Biol 331: 340-349. doi: 10. 1016/j.ydbio.2009.04.016 PMID: 19389392
30. Brown S, Teo A, Pauklin S, Hannan N, Cho CH, et al. (2011) Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors. Stem Cells 29: 1176-1185. doi: 10.1002/stem.666 PMID: 21630377
31. Kumar A, Novoselov V, Celeste AJ, Wolfman NM, ten Dijke P, et al. (2001) Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads. The Journal of biological chemistry 276: 656-661. doi: 10.1074/jbc.M004649200 PMID: 11024047
32. Yan YT, Liu JJ, Luo Y, E C, Haltiwanger RS, et al. (2002) Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway. Molecular and cellular biology 22: 4439-4449. doi: 10.1128/MCB.22. 13.4439-4449.2002 PMID: 12052855
33. Gritsman K, Zhang J, Cheng S, Heckscher E, Talbot WS, et al. (1999) The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell 97: 121-132. doi: 10.1016/S0092-8674(00)80720-5 PMID: 10199408
34. Wu X, Gallo KA (2013) The 18-kDa translocator protein (TSPO) disrupts mammary epithelial morphogenesis and promotes breast cancer cell migration. PLoS One 8: e71258. doi: 10.1371/journal.pone. 0071258 PMID: 23967175
35. Humphries B, Wang Z, Oom AL, Fisher T, Tan D, et al. (2014) MicroRNA-200b targets protein kinase Calpha and suppresses triple-negative breast cancer metastasis. Carcinogenesis. doi: 10.1093/carcin/ bgu133 PMID: 24925028
36. Sako D, Grinberg AV, Liu J, Davies MV, Castonguay R, et al. (2010) Characterization of the ligand binding functionality of the extracellular domain of activin receptor type IIb. The Journal of biological chemistry 285: 21037-21048. doi: 10.1074/jbc.M110.114959 PMID: 20385559
37. Townson SA, Martinez-Hackert E, Greppi C, Lowden P, Sako D, et al. (2012) Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex. The Journal of biological chemistry 287: 27313-27325. doi: 10.1074/jbc.M112.377960 PMID: 22718755
38. De Crescenzo G, Pham PL, Durocher Y, O'Connor-McCourt MD (2003) Transforming growth factorbeta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding. J Mol Biol 328: 1173-1183. PMID: 12729750
39. Gray PC, Harrison CA, ValeW(2003) Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proceedings of the National Academy of Sciences of the United States of America 100: 5193-5198. doi: 10.1073/pnas.0531290100 PMID: 12682303
40. Yu X, He F, Zhang T, Espinoza-Lewis RA, Lin L, et al. (2008) Cerberus functions as a BMP agonist to synergistically induce nodal expression during left-right axis determination in the chick embryo. Dev Dyn 237: 3613-3623. doi: 10.1002/dvdy.21769 PMID: 18985739
41. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM (1998) The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1: 673-683. doi: 10.1016/S1097-2765(00)80067-2 PMID: 9660951
42. Chi L, Saarela U, Railo A, Prunskaite-Hyyrylainen R, Skovorodkin I, et al. (2011) A secreted BMP antagonist, Cer1, fine tunes the spatial organization of the ureteric bud tree during mouse kidney development. PLoS One 6: e27676. doi: 10.1371/journal.pone.0027676 PMID: 22114682
43. Cai W, Albini S, Wei K, Willems E, Guzzo RM, et al. (2013) Coordinate Nodal and BMP inhibition directs Baf60c-dependent cardiomyocyte commitment. Genes Dev 27: 2332-2344. doi: 10.1101/gad.225144. 113 PMID: 24186978
44. Foley AC, Korol O, Timmer AM, Mercola M (2007) Multiple functions of Cerberus cooperate to induce heart downstream of Nodal. Developmental biology 303: 57-65. doi: 10.1016/j.ydbio.2006.10.033 PMID: 17123501
45. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, et al. (1998) Human Smad3 and Smad4 are sequence- specific transcription activators. Mol Cell 1: 611-617. doi: 10.1016/S1097-2765(00)80061-1 PMID: 9660945
46. Quail DF, Walsh LA, Zhang G, Findlay SD, Moreno J, et al. (2012) Embryonic protein nodal promotes breast cancer vascularization. Cancer research 72: 3851-3863. doi: 10.1158/0008-5472.CAN-11- 3951 PMID: 22855743
47. Strizzi L, Hardy KM, Kirschmann DA, Ahrlund-Richter L, Hendrix MJ (2012) Nodal expression and detection in cancer: experience and challenges. Cancer research 72: 1915-1920. doi: 10.1158/0008- 5472.CAN-11-3419 PMID: 22508696
48. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, et al. (2006) CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8: R59. doi: 10.1186/bcr1610 PMID: 17062128
49. Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP (1994) Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31: 325-335. doi: 10.1007/ BF00666165 PMID: 7881109
50. Schier AF (2003) Nodal signaling in vertebrate development. Annual review of cell and developmental biology 19: 589-621. doi: 10.1146/annurev.cellbio.19.041603.094522 PMID: 14570583
51. Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700. doi: 10.1016/S0092-8674(03)00432-X PMID: 12809600
52. Calvanese L, Saporito A, Oliva R, D'Auria G, Pedone C, et al. (2009) Structural insights into the interaction between the Cripto CFC domain and the ALK4 receptor. Journal of peptide science: an official publication of the European Peptide Society 15: 175-183. doi: 10.1002/psc.1091
53. Kelber JA, Shani G, Booker EC, Vale WW, Gray PC (2008) Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal. The Journal of biological chemistry 283: 4490-4500. doi: 10.1074/jbc.M704960200 PMID: 18089557
54. Adkins HB, Bianco C, Schiffer SG, Rayhorn P, Zafari M, et al. (2003) Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. The Journal of clinical investigation 112: 575-587. doi: 10.1172/JCI17788 PMID: 12925698
55. Fuerer C, Nostro MC, Constam DB (2014) Nodal.Gdf1 Heterodimers with Bound Prodomains Enable Serum-independent Nodal Signaling and Endoderm Differentiation. J Biol Chem 289: 17854-17871. doi: 10.1074/jbc.M114.550301 PMID: 24798330
56. Hinck AP (2012) Structural studies of the TGF-betas and their receptors-insights into evolution of the TGF-beta superfamily. FEBS Lett 586: 1860-1870. doi: 10.1016/j.febslet.2012.05.028 PMID: 22651914
57. Groppe J, Hinck CS, Samavarchi-Tehrani P, Zubieta C, Schuermann JP, et al. (2008) Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol Cell 29: 157-168. doi: 10.1016/j.molcel.2007.11.039 PMID: 18243111
58. Nolan K, Kattamuri C, Luedeke DM, Deng X, Jagpal A, et al. (2013) Structure of protein related to Dan and Cerberus: insights into the mechanism of bone morphogenetic protein antagonism. Structure 21: 1417-1429. doi: 10.1016/j.str.2013.06.005 PMID: 23850456